Related references
Note: Only part of the references are listed.Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia
Robert de Jonge et al.
BLOOD (2009)
Advances in individual prediction of methotrexate toxicity: a review
Kjeld Schmiegelow
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study
K. Schmiegelow et al.
LEUKEMIA (2009)
Outcome of ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia in the NOPHO-ALL-1992 protocol:: frequent late relapses but good overall survival
Erik Forestier et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Pharmacogenetics Influence Treatment Efficacy in Childhood Acute Lymphoblastic Leukemia
Marie Louise Davidsen et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2008)
Reduced folate carrier polymorphism determines methotrexate uptake by B cells and CD4+T cells
B. Baslund et al.
RHEUMATOLOGY (2008)
Reduced folate carrier-1 80G > A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis
M. Drozdzik et al.
PHARMACOGENOMICS JOURNAL (2007)
High leucovorin doses during high-dose methotrexate treatment may reduce the cure rate in childhood acute lymphoblastic leukemia
T. V. Ch Skarby et al.
LEUKEMIA (2006)
Pharmacogenetics of outcome in children with acute lymphoblastic leukemia
JCC Rocha et al.
BLOOD (2005)
Down syndrome, drug metabolism, and chromosome 21
JW Taub et al.
PEDIATRIC BLOOD & CANCER (2005)
Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis
T Dervieux et al.
ARTHRITIS AND RHEUMATISM (2004)
Reduced folate carrier and dihydrofolate reductase expression in acute lymphocytic leukemia may predict outcome: A Children's Cancer Group study
AS Levy et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2003)
Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia
C Laverdière et al.
BLOOD (2002)
Continuing therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of methotrexate, 6-mercaptopurine and 6-thioguanine
EJ Estlin
CANCER TREATMENT REVIEWS (2001)
Improving outcome through two decades in childhood ALL in the Nordic countries:: the impact of high-dose methotrexate in the reduction of CNS irradiation
G Gustafsson et al.
LEUKEMIA (2000)
A polymorphism (80G->A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia
A Chango et al.
MOLECULAR GENETICS AND METABOLISM (2000)
Share Paper
